methylprednisolone has been researched along with pentoxifylline in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Abramowicz, D; Bemelmans, MH; Buurman, WA; Goldman, M; Gouma, DJ | 1 |
| Fung, JJ; Murase, N; Pan, F; Rao, AS; Rice, G; Singer, JW; Starzl, TE; Subbotin, V; Sun, H; Todo, S; Valdivia, LA | 1 |
| Chelstrom, LM; Clementson, D; Covalciuc, K; Gunther, R; Irvin, JD; Johnson, B; Myers, DE; Schneider, EA; Uckun, FM; Wendorf, HR | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Briggs, WA; Burdick, J; Choi, M; Eustace, J; Gimenez, LF; Mathew, S; Scheel, PJ | 1 |
| Briggs, WA; Burdick, J; Choi, M; Orgul, O; Scheel, PJ; Wu, Q | 1 |
| Briggs, WA; Burdick, JF; Choi, MJ; Eustace, J; Gimenez, LF; Scheel, PJ | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| Alessi, E; Marzano, AV; Vanotti, M | 1 |
| Cankaya, H; Içli, M; Kiriş, M; Kutluhan, A | 1 |
| Akkoç, A; Misirlioğlu, D; Polat, U; Sevimli, A; Uğuz, C; Yalçin, M | 1 |
| Ben Gamra, O; Ben Rejab, I; Bhar, H; El Khedim, A; Hariga, I; Mbarek, C; Sghaier, L; Zribi, S | 1 |
| Bruschini, L; Bruschini, P; Dallan, I; Fattorp, B; Ferraro, G; Nacci, A; Rognini, F; Traino, AC | 1 |
| Aricha, R; Feferman, T; Fuchs, S; Menon, RT; Souroujon, MC | 1 |
| Breil, J; Labus, J; Michel, O; Stützer, H | 1 |
| Aydin, F; Fidan, E; Fidan, M; Kavgaci, H; Ozdemir, F | 1 |
| Bisaga, GN; Boĭko, AN; Mel'nik, IuB; Odinak, MM; Popova, NF | 1 |
| Aktas, M; Erken, HY; Ofluoglu, O; Topal, C; Yildiz, M | 1 |
| Grzeszczak, W; Król, R; Więcek, A; Wystrychowski, A; Wystrychowski, G; Wystrychowski, W | 1 |
| Barton, B; Casey, L; Cuthbert, J; Dasarathy, S; Holbein, MEB; Kroll-Desrosiers, A; McClain, CJ; McCullough, AJ; Min, HA; Mitchell, M; Nagy, LE; Radaeva, S; Szabo, G; Tornai, D | 1 |
2 review(s) available for methylprednisolone and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss.
Topics: Administration, Oral; Citrates; Controlled Clinical Trials as Topic; Dexamethasone; Dextrans; Epoprostenol; Follow-Up Studies; Hearing Loss, Sudden; Humans; Infusions, Intravenous; Methylprednisolone; Pentoxifylline; Prednisone; Procaine | 2010 |
3 trial(s) available for methylprednisolone and pentoxifylline
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
[Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antioxidants; Autoantibodies; Cognition; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Flavin Mononucleotide; Humans; Inosine Diphosphate; Lipid Peroxidation; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelin Sheath; Niacinamide; Pentoxifylline; Succinates; Vitamin B Complex; Young Adult | 2011 |
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Topics: Adrenal Cortex Hormones; Adult; End Stage Liver Disease; Female; Hepatitis, Alcoholic; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Receptors, Interleukin-1; Severity of Illness Index; Zinc | 2022 |
24 other study(ies) available for methylprednisolone and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
Topics: Animals; Antibodies, Monoclonal; CD3 Complex; Cricetinae; Female; Interferon-gamma; Lymphocyte Activation; Methylprednisolone; Mice; Mice, Inbred DBA; Pentoxifylline; Receptors, Tumor Necrosis Factor; Renal Circulation; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1994 |
Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Heterophile; Complement C3; Graft Survival; Guinea Pigs; Heart Transplantation; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Intraoperative Period; Methylprednisolone; Pentoxifylline; Phosphatidic Acids; Rats; Rats, Inbred Lew; Transplantation, Heterologous | 1996 |
Toxicity profile of the investigational new biotherapeutic agent, B43 (anti-CD19)-pokeweed antiviral protein immunotoxin.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigens, CD19; Antineoplastic Agents, Phytogenic; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Dopamine; Female; Immunotoxins; Injections, Intraperitoneal; Injections, Intravenous; Kidney Tubular Necrosis, Acute; Methylprednisolone; Mice; Mice, Inbred BALB C; Muscular Diseases; N-Glycosyl Hydrolases; Pentoxifylline; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Single-Blind Method | 1996 |
Pentoxifylline potentiates in vitro lymphocyte suppression by glucocorticoids and immunosuppressive drugs.
Topics: Adult; Aged; Analysis of Variance; Cyclosporine; Drug Synergism; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphocytes; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Prednisolone | 1998 |
Lymphocyte suppression by rolipram with other immunosuppressive drugs.
Topics: Adult; Aged; Cell Division; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Leukocytes, Mononuclear; Lymphocytes; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Tacrolimus; Thymidine; Tritium | 1999 |
Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid.
Topics: Cells, Cultured; Cyclosporine; Drug Combinations; Enzyme Inhibitors; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lymphocytes; Methylprednisolone; Mycophenolic Acid; Pentoxifylline; Prednisolone; Tacrolimus | 1999 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Widespread livedoid vasculopathy.
Topics: Adult; Autoimmune Diseases; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Methylprednisolone; Pentoxifylline; Physical Examination; Risk Assessment; Severity of Illness Index; Skin Diseases, Vascular; Treatment Outcome | 2003 |
Retrospective analysis of our cases with sudden hearing loss.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anticoagulants; Audiometry, Pure-Tone; Auditory Threshold; Child; Dextrans; Diazepam; Drug Therapy, Combination; Female; Glucocorticoids; Hearing Loss, Sudden; Humans; Male; Methylprednisolone; Middle Aged; Papaverine; Pentoxifylline; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vasodilator Agents | 2003 |
The effects of vitamin A, pentoxyfylline and methylprednisolone on experimentally induced amyloid arthropathy in brown layer chicks.
Topics: Amyloidosis; Animals; Anti-Inflammatory Agents; Chickens; Enzyme Inhibitors; Freund's Adjuvant; Joint Diseases; Methylprednisolone; Pentoxifylline; Poultry Diseases; Vitamin A | 2005 |
[Idiopathic sudden sensorineural hearing loss. What's the appropriate management?].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspirin; Audiometry, Pure-Tone; Child; Female; Glucocorticoids; Hearing; Hearing Loss, Sudden; Hospitalization; Humans; Hyperbaric Oxygenation; Male; Methylprednisolone; Middle Aged; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Recovery of Function; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 2007 |
Transtympanic steroids in refractory sudden hearing loss. Personal experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Heparin, Low-Molecular-Weight; Humans; Injections; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Prospective Studies; Severity of Illness Index; Sodium Bicarbonate; Tympanic Membrane; Vasodilator Agents | 2006 |
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Topics: Animals; Antibodies; Body Weight; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Methylprednisolone; Muscle, Skeletal; Myasthenia Gravis, Autoimmune, Experimental; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Lew; Receptors, Cholinergic; Severity of Illness Index | 2008 |
Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Anticonvulsants; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Drug Therapy, Combination; Free Radical Scavengers; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Phenytoin; Prognosis; Rectal Neoplasms; Stevens-Johnson Syndrome | 2012 |
Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken.
Topics: Adipogenesis; Animals; Bone Marrow Cells; Chickens; Disease Models, Animal; Femur Head; Femur Head Necrosis; Glucocorticoids; Injections, Intramuscular; Male; Methylprednisolone; Necrosis; Pentoxifylline; Vasodilator Agents | 2012 |
Pentoxifylline and Methylprednisolone Additively Alleviate Kidney Failure and Prolong Survival of Rats after Renal Warm Ischemia-Reperfusion.
Topics: Acute Kidney Injury; Animals; Glucocorticoids; Kidney; Male; Methylprednisolone; Pentoxifylline; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vasodilator Agents | 2018 |